Menu
GeneBe

DHFR2

dihydrofolate reductase 2

Basic information

Region (hg38): 3:94047835-94063389

Previous symbols: [ "DHFRP4", "DHFRL1" ]

Links

ENSG00000178700NCBI:200895OMIM:616588HGNC:27309Uniprot:Q86XF0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the DHFR2 gene.

  • Joubert syndrome 8 (63 variants)
  • not provided (9 variants)
  • not specified (5 variants)
  • Inborn genetic diseases (5 variants)
  • Joubert syndrome and related disorders (1 variants)
  • Familial aplasia of the vermis (1 variants)
  • Joubert syndrome 1 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the DHFR2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
0
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
33
clinvar
34
clinvar
2
clinvar
70
Total 0 1 33 34 2

Variants in DHFR2

This is a list of pathogenic ClinVar variants found in the DHFR2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-94049358-G-A not specified Benign/Likely benign (Mar 01, 2019)263012
3-94049386-T-C Joubert syndrome 8 Likely benign (Jul 17, 2023)2148367
3-94049389-T-C not specified Likely benign (Jul 10, 2017)510717
3-94049403-T-A Joubert syndrome 8 Uncertain significance (Feb 04, 2022)860194
3-94049410-T-C Joubert syndrome 8 Likely benign (May 01, 2023)1548359
3-94049413-T-C Joubert syndrome 8 Benign/Likely benign (Aug 23, 2023)1169343
3-94049414-A-G Joubert syndrome 8 Uncertain significance (Apr 20, 2021)1489468
3-94049424-C-G not specified • Joubert syndrome 8 Benign (Jan 31, 2024)128452
3-94049426-A-G Joubert syndrome 8 • ARL13B-related disorder Likely benign (Jan 26, 2024)346912
3-94049431-A-G Joubert syndrome 8 Likely benign (Aug 31, 2022)1605025
3-94049439-T-C Joubert syndrome 8 Uncertain significance (Oct 04, 2022)1018029
3-94049448-A-G Joubert syndrome 8 • Inborn genetic diseases Conflicting classifications of pathogenicity (Feb 23, 2022)999431
3-94049450-C-T Joubert syndrome 8 Uncertain significance (Aug 20, 2020)1006971
3-94049451-A-G Joubert syndrome 8 • Inborn genetic diseases Uncertain significance (Sep 01, 2022)939183
3-94049452-C-G Joubert syndrome 8 Uncertain significance (Jul 23, 2022)1713530
3-94049454-G-A Joubert syndrome 8 Uncertain significance (Jan 03, 2020)634456
3-94049470-T-C Joubert syndrome 8 Likely benign (Aug 04, 2021)1533440
3-94049471-A-G Joubert syndrome 8 Uncertain significance (Nov 01, 2022)1060069
3-94049475-A-G Joubert syndrome 8 Uncertain significance (Jun 06, 2021)1359528
3-94049498-A-T Joubert syndrome 8 Uncertain significance (Jul 19, 2022)957751
3-94049499-C-T Joubert syndrome 8 • Inborn genetic diseases Uncertain significance (Jul 15, 2022)1061421
3-94049500-G-A Joubert syndrome 8 Likely benign (Oct 05, 2023)1576771
3-94049506-C-T Joubert syndrome 8 Likely benign (Sep 20, 2023)2976081
3-94049513-C-G Joubert syndrome 8 Uncertain significance (Apr 12, 2022)2157303
3-94049514-C-T Joubert syndrome 8 Uncertain significance (Jan 01, 2019)634457

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
DHFR2protein_codingprotein_codingENST00000394221 115554
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.2250.657125603041256070.0000159
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5978197.60.8300.000005041243
Missense in Polyphen3031.1310.96368420
Synonymous-0.8304235.71.180.00000208336
Loss of Function1.1013.100.3232.00e-738

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00005780.0000578
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.000.00
European (Non-Finnish)0.000008820.00000880
Middle Eastern0.00005440.0000544
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Key enzyme in folate metabolism. Contributes to the de novo mitochondrial thymidylate biosynthesis pathway. Required to prevent uracil accumulation in mtDNA. Binds its own mRNA and that of DHFR. {ECO:0000269|PubMed:21876184, ECO:0000269|PubMed:21876188}.;
Pathway
Folate biosynthesis - Homo sapiens (human);One carbon pool by folate - Homo sapiens (human);Trans-sulfuration and one carbon metabolism;One carbon metabolism and related pathways;Metabolism;Metabolism of folate and pterines;dTMP <i>de novo</i> biosynthesis (mitochondrial);Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors (Consensus)

Intolerance Scores

loftool
rvis_EVS
0.19
rvis_percentile_EVS
66.82

Haploinsufficiency Scores

pHI
0.445
hipred
N
hipred_score
0.216
ghis
0.563

Essentials

essential_gene_CRISPR
essential_gene_CRISPR2
essential_gene_gene_trap
N
gene_indispensability_pred
gene_indispensability_score

Gene ontology

Biological process
one-carbon metabolic process;thymidine biosynthetic process;dihydrofolate metabolic process;tetrahydrofolate metabolic process;tetrahydrofolate biosynthetic process;folic acid metabolic process;oxidation-reduction process
Cellular component
mitochondrion;mitochondrial inner membrane;mitochondrial matrix
Molecular function
mRNA binding;dihydrofolate reductase activity;NADP binding